Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Keratosis, Actinic × Therapeutics × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Lung Neoplasms 2 Depression 2 Carcinoma, Non-Small-Cell Lung 2 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Treatment Adherence and Compliance 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Postoperative Hemorrhage 1 Peripheral Lung Tumor 1 Patient Acceptance of Health Care 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Obesity 1 Mycoses 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Imipramine 2 green tea extract polyphenone E 1 Tomography, Optical Coherence 1 Therapeutics 1 Photochemotherapy 1 Ointments 1 Gels 1 Fluorouracil 1 Cryotherapy 1 Control Groups 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡